Sandoz US News


Fougera Announces Plans for New State-of-the-Art Facilities

Melville, NY, March 7, 2016 – Fougera Pharmaceuticals Inc. (“Fougera”), a wholly owned subsidiary of Sandoz Inc. (“Sandoz”), operating its PharmaDerm® branded and generic dermatology businesses, has announced plans to consolidate its two production facilities, currently located in Melville and Hicksville, N.Y. The consolidation—which will move all of the company’s operations to the Melville site—is expected to take place during the next four to five years, with a target completion some time in 2020.

Sandoz launches generic version of SKELAXIN® in the US

Princeton, New Jersey, November 19, 2015 – Sandoz today announced the US market re-introduction of metaxalone tablets, a generic version of SKELAXIN® (distributed by Pfizer Inc)1.

Generic medicines saved US healthcare system more than USD 250 billion in 2014 alone

Generic medicines saved the US healthcare system a record USD 254 billion in 2014, according to a new report compiled by the IMS Institute for Healthcare Informatics on behalf of the US Generic Pharmaceutical Association (GPhA).

Sandoz Careers


Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

 Learn more about a career with Sandoz in the US


Vets Hiring 300

Transitioning to civilian service soon? Consider a career with Sandoz, a Novartis company. Learn about our mission, and why you should explore being a part of our team.




Slideshow Background Images